Charcot-Marie-Tooth disease axonal type 2N (CMT2N) is a rare inherited nerve disease that mainly damages the long “wires” of the nerves, called axons. It usually affects the nerves of the feet and hands first, so people slowly develop weakness, thin muscles, and reduced feeling in the legs and later the arms. CMT2N is usually caused by a harmful change (mutation) in the AARS gene on chromosome 16, and it is often passed in an autosomal dominant way, meaning one changed gene from a parent can be enough to cause the disease. ZFIN+1
Charcot-Marie-Tooth disease axonal type 2N (CMT2N) is a rare, inherited nerve disease. It mainly damages the long nerves that go from the spinal cord to the feet and, later, to the hands. Doctors call this a “peripheral sensorimotor neuropathy,” which means it affects feeling (sensory) and movement (motor) in the limbs. In CMT2N the main problem is in the nerve fiber itself (the axon), not the myelin covering, so it is called an “axonal” type. NCBI+1
CMT2N is usually described as a mild and slow-progressing form of Charcot-Marie-Tooth disease. Most people first notice symptoms in the lower legs and feet, such as numbness, tingling, and weakness. Reflexes at the ankles are often absent, and knee reflexes are weak. Over many years, the weakness can slowly move upward and can later affect the hands, but many people stay able to walk and live independent lives. NCBI+1
The basic cause of CMT2N is a change (mutation) in a single gene called AARS, which gives the body instructions to make an enzyme named alanyl-tRNA synthetase. This enzyme helps build proteins in every cell. A harmful mutation in this gene makes the enzyme work in an abnormal way in nerve cells. Those nerve cells then become stressed and start to slowly degenerate, especially in the longest nerves in the legs and arms. MalaCards+2MedlinePlus+2
CMT2N is usually passed down in an autosomal dominant way. This means a person can get the condition if they inherit one changed copy of the AARS gene from either parent. Sometimes the mutation appears for the first time in a person (a “de novo” mutation) with no family history. MalaCards
Important note: The information here is for learning only. It cannot replace medical advice. If you think you or someone in your family may have CMT, you should see a neurologist or genetic specialist.
Other names
Charcot-Marie-Tooth disease axonal type 2N is known by several different names in medical books. One common name is “Charcot-Marie-Tooth disease, axonal, type 2N (CMT2N)”, which simply repeats the full medical label. MalaCards+1
Another name that doctors use is “AARS-related axonal Charcot-Marie-Tooth disease.” This name reminds clinicians that the AARS gene is the main gene involved in this type of CMT. MalaCards+1
Sometimes it is called “autosomal dominant Charcot-Marie-Tooth disease type 2N.” This version of the name tells us the inheritance pattern (autosomal dominant), the broad group (type 2, or axonal), and the specific subtype (N). orpha.net+1
A more general but less precise term is “axonal Charcot-Marie-Tooth neuropathy due to aminoacyl-tRNA synthetase mutation.” This reminds us that AARS belongs to a large family of enzymes called aminoacyl-tRNA synthetases, and several of these enzymes can cause axonal neuropathies when mutated. ResearchGate
Types and related forms
Charcot-Marie-Tooth disease is divided into several main types. CMT1 mainly affects the myelin sheath (the insulation around the nerve). CMT2 is the axonal form, where the main damage is in the nerve fiber itself. There are also other groups like CMT4 (usually recessive) and CMTX (X-linked), and some “intermediate” forms that show mixed features. Wikipedia+2MDPI+2
Within CMT2, there are many subtypes, named with letters (2A, 2B, 2C … 2N, etc.). Each subtype is linked with a specific gene. For example, CMT2A is linked to MFN2, while CMT2N is linked to AARS. These lettered types help doctors connect the clinical picture (how the patient looks and feels) with the genetic cause. Wikipedia+1
CMT2N itself can show some variation. Some people have very mild symptoms that appear in late adolescence or adulthood and stay stable for many years. Others may notice leg weakness and sensory loss earlier in life, sometimes in childhood, and have more foot deformities. This range of symptoms is called “variable expressivity,” and it is common in inherited nerve diseases like CMT. orpha.net+1
CMT2N is also part of a wider family of diseases called aminoacyl-tRNA synthetase–related neuropathies. Different synthetase genes (such as AARS, GARS1, and others) can cause different subtypes of CMT or pure motor neuropathy. Although the exact mechanisms differ, they share a similar basic problem: damage to long motor and sensory axons. ResearchGate+1
Causes
Note: In strict medical terms, the main cause of CMT2N is a mutation in the AARS gene. The list below includes that primary cause plus related mechanisms and factors that can influence how the disease appears or worsens over time.
Inherited AARS gene mutation (main cause). The primary cause of CMT2N is a harmful change in one copy of the AARS gene. This mutation changes how the alanyl-tRNA synthetase enzyme works in nerve cells, leading over time to damage and loss of long peripheral axons. MalaCards+2MedlinePlus+2
Autosomal dominant transmission in families. A parent with a pathogenic AARS mutation has a 50% chance of passing it to each child. When this happens, the child has a high chance of developing CMT2N at some point in life, although severity can be different from the parent. orpha.net+1
De novo AARS mutations. In some people, the mutation arises for the first time in that person’s egg or sperm cell, or very early after conception. There may be no previous family history, but the person can still pass the mutation to their children. MalaCards
Missense mutations changing the enzyme’s active site. Many AARS mutations in CMT2N are missense changes that alter one amino acid in the enzyme’s active site. This can disturb how the enzyme attaches the amino acid alanine to its tRNA, stressing nerve cells that need precise protein production. MalaCards+1
Mutations affecting tRNA-binding domains. Other mutations may affect parts of the enzyme that bind to tRNA. This can reduce the efficiency or accuracy of protein synthesis in neurons, making them more fragile over time. MedlinePlus+1
Toxic gain-of-function of mutant AARS protein. Some evidence suggests that mutant aminoacyl-tRNA synthetase proteins may gain new harmful effects, such as abnormal binding to other proteins or pathways inside neurons, which can trigger cell stress and degeneration. ResearchGate
Disruption of axonal transport. Long peripheral axons depend on steady movement of proteins, energy packets (mitochondria), and other materials along microtubules. Mutant AARS can indirectly disturb these transport systems, making long leg and arm nerves especially vulnerable. ScienceDirect+1
Chronic axonal degeneration in distal nerves. Because the longest nerves are most sensitive to stress, they begin to degenerate at their far ends first. This “length-dependent” loss explains why symptoms start in the feet and later reach the hands. MDPI+1
Secondary changes in Schwann cells and myelin. Even though CMT2N is an axonal type, damaged axons can also cause changes in their supporting Schwann cells. This can lead to secondary myelin abnormalities, which further slow nerve signaling. Wikipedia+1
Cell stress from misfolded proteins. Mutant AARS may misfold, build up, or overload quality-control systems inside neurons. The resulting cell stress can gradually push nerve cells towards dysfunction and death. ResearchGate
Oxidative and mitochondrial stress. Abnormal protein handling can also disturb energy production in nerve cells. Mitochondria may not work well, creating energy shortages and oxidative stress that further damage axons. Wikipedia+1
Age-related accumulation of nerve damage. Even when the mutation is present from birth, symptoms often show later because nerve damage builds up slowly over many years. Age acts as a natural “accelerator” of the disease process. orpha.net+1
Coexisting diabetes or metabolic disease (worsening factor). Diabetes and other metabolic problems do not cause CMT2N, but they can cause extra nerve damage (diabetic neuropathy). When combined with CMT2N, they can make symptoms worse and appear earlier. MD Searchlight
Vitamin B12 or folate deficiency (worsening factor). Low B12 or folate levels can independently injure nerves. In someone with CMT2N, these deficiencies may increase numbness and weakness. Treating the deficiency cannot remove the gene mutation but may improve overall nerve function. MD Searchlight
Thyroid dysfunction (worsening factor). Thyroid hormone problems, especially untreated hypothyroidism, can cause or worsen neuropathy. In a person with CMT2N, poor thyroid control can make fatigue, weakness, and nerve symptoms more obvious. MD Searchlight
Neurotoxic medications. Some chemotherapy drugs, high-dose certain antibiotics, or other neurotoxic medicines can damage peripheral nerves. Doctors try to avoid or carefully monitor these medicines in people with known CMT to prevent extra nerve injury. MD Searchlight+1
Alcohol misuse. Heavy, long-term alcohol use is toxic to nerves and can cause alcoholic neuropathy. If a person with CMT2N drinks heavily, this can add more nerve damage on top of the genetic problem. MD Searchlight
Repeated mechanical pressure on nerves. Tight footwear, frequent ankle injuries, or long-term pressure on nerves at the knee or ankle can further injure already weak nerves in CMT2N. People are often advised to protect their feet and ankles carefully. Cleveland Clinic+1
Lack of physical activity. The nerve problem is primary, but low activity means muscles lose strength and flexibility faster. This can increase weakness and joint stiffness, making CMT2N appear more severe. Cleveland Clinic+1
Poorly fitted shoes and untreated foot deformities. High arches, hammertoes, and foot drop can worsen if shoes do not support the foot properly. This can increase pain, calluses, and falls, giving the impression of faster disease progression even when the genetic damage is unchanged. Cleveland Clinic+1
Symptoms
Numbness in the feet. One of the first signs is a “dead” or numb feeling in the toes and soles. The person may feel less touch, temperature, or pain in these areas because the sensory axons are slowly being lost. NCBI+1
Tingling or burning sensations. Some people feel pins-and-needles, buzzing, or burning in their feet or lower legs. These abnormal sensations come from damaged sensory nerves sending confused signals to the brain. Wikipedia+1
Weakness in the ankles and feet. The small muscles that lift the front of the foot become weak. This makes it harder to raise the toes or ankle when walking, which is a classic feature of axonal CMT. NCBI+1
Foot drop and high-stepping gait. Because the foot cannot lift well, it may drag on the ground (foot drop). To avoid tripping, the person may lift their knees higher when walking, creating a high-stepping gait. Wikipedia+1
Frequent tripping and falls. Weak foot muscles and reduced feeling make it easy to trip over small objects or uneven ground. Minor falls and ankle sprains can become common, especially in the dark or on rough surfaces. Wikipedia+1
High-arched feet (pes cavus). Over time, the imbalance between different foot muscles can pull the arch higher than normal, causing a rigid, high-arched foot. This can make shoe fitting difficult and can cause pressure points on the sole. Wikipedia+1
Hammertoes or claw toes. The toes may become bent or clawed because the small muscles inside the foot weaken. Tendons pull unevenly on the toes, making them curl and sometimes rub painfully against shoes. Wikipedia+1
Reduced or absent ankle reflexes. When a doctor taps the Achilles tendon at the back of the ankle, the normal reflex kick is weak or absent. This loss of reflex is a key sign of peripheral neuropathy in CMT2N. NCBI+1
Wasting of lower leg muscles. As nerves die back, the calf and shin muscles shrink. The lower legs can look thin and “inverted-bottle shaped,” with relatively normal thighs but small calves. Wikipedia+1
Hand weakness (later). In many patients, hand muscles become weak later in the disease. This makes it harder to grip objects, open jars, write, type, or do fine tasks like buttoning clothes. NCBI+1
Loss of sensation in hands. As the disease progresses up the arms, feeling in the fingers can also drop. People may not notice cuts, burns, or temperature changes, which can lead to injuries. NCBI+1
Leg fatigue and cramps. Weak muscles have to work harder, so the legs may tire quickly, especially after walking or standing for a long time. Some people also experience painful muscle cramps in the calves or feet. Wikipedia+1
Balance problems. Because both muscle strength and sensation are affected, balance can become poor. Standing on uneven ground or in the dark is especially hard, and some people need handrails or walking aids as they get older. Cleveland Clinic+1
Mild spinal or posture changes. In some people, long-standing muscle imbalance around the trunk and legs can lead to mild curvature of the spine or changes in posture, although this is usually less severe than in some other neuromuscular diseases. Wikipedia+1
Neuropathic pain (sometimes). Many people with CMT2N have little or no pain, but some may feel burning, stabbing, or electric-shock pains due to irritated sensory nerve fibers. This type of pain is called neuropathic pain and can vary from mild to severe. MD Searchlight+1
Diagnostic tests
Physical examination tests
General neurological examination. The doctor first does a full nerve and muscle exam. They check muscle bulk, strength, tone, reflexes, and sensation in the arms and legs. This helps show the pattern of weakness and numbness and suggests that the main problem is a length-dependent peripheral neuropathy. ScienceDirect+1
Gait observation. The doctor watches how the person walks across the room. They look for high-stepping gait, foot drop, uneven steps, or use of the sides of the feet. This simple test tells a lot about how much the leg weakness affects daily movement. Wikipedia+1
Foot and ankle inspection. The feet are examined for high arches, flat feet, hammertoes, calluses, pressure sores, or ankle deformity. Visible changes in the shape of the feet are classic clues that point toward a long-standing CMT-type neuropathy. Wikipedia+1
Reflex testing. The doctor taps various tendons with a reflex hammer, especially at the knees and ankles. In CMT2N, knee reflexes are often reduced and ankle reflexes often disappear completely, showing that the peripheral reflex arc is damaged. NCBI+1
Sensory testing. Light touch, pinprick, vibration, and position sense are tested in the toes, feet, and fingers. Loss of vibration or pinprick at the toes, moving up the leg in a “stocking” pattern, supports the diagnosis of a distal sensorimotor neuropathy such as CMT2N. NCBI+1
Romberg balance test. The person stands with feet together, first with eyes open and then closed. If balance becomes much worse with eyes closed, it suggests that the body is relying heavily on vision because position sense from the feet is impaired by neuropathy. MD Searchlight+1
Manual tests
Manual muscle testing of feet and hands. The doctor asks the person to push and pull against resistance in the ankles, toes, wrists, and fingers. By grading the strength of each muscle group, the doctor can map which nerves are most affected and how severe the weakness is. ScienceDirect+1
Grip strength test. A hand-held device (dynamometer) or simple resistance test is used to measure grip strength. Reduced grip shows hand muscle involvement, which is common in many CMT2 forms and may appear in CMT2N later in the disease. NCBI+1
Heel and toe walking test. The person is asked to walk on their heels and then on their toes. Difficulty walking on heels often indicates weakness in the muscles that lift the front of the foot, a hallmark of CMT-related foot drop. Wikipedia+1
Timed walking test. The doctor may time how long it takes to walk a set distance (for example, 10 meters) or to climb a short set of stairs. Comparing times over months or years helps track how the condition is progressing and whether treatments like physiotherapy or braces are helping. MDPI+1
Functional hand dexterity test. Simple tasks like buttoning, picking up small objects, or tracing shapes can show how the disease affects fine motor skills. Slower performance or dropping objects suggests more involvement of the hand muscles and nerves. NCBI+1
Lab and pathological tests
Basic blood tests to exclude other neuropathies. Blood tests may check blood sugar, vitamin B12, thyroid function, kidney and liver function, and sometimes infections or autoimmune markers. These tests do not diagnose CMT2N directly but help rule out other treatable causes of neuropathy that might be confused with CMT. MD Searchlight+1
Genetic test for AARS mutation. A blood sample can be sent for genetic testing that looks for known mutations in genes linked to CMT. In CMT2N, the key is to find a pathogenic variant in the AARS gene. Finding this mutation confirms the diagnosis and allows family testing and genetic counseling. MalaCards+2ScienceDirect+2
Targeted CMT gene panels or exome sequencing. Instead of testing one gene at a time, many centers now use next-generation sequencing panels that include dozens of CMT-related genes, or even exome sequencing. This is helpful because many CMT genes give similar clinical pictures, and the exact gene (like AARS) is not always obvious at first. www.elsevier.com+1
Nerve biopsy (now rarely needed). In unclear cases, a small piece of a peripheral nerve (often from the ankle area) may be removed and examined under a microscope. In axonal CMT, the pathologist may see loss of axons and some secondary myelin changes. However, because genetic tests are now better, nerve biopsy is used much less often. www.elsevier.com+1
Muscle biopsy (sometimes used). A small sample of muscle may be taken to check for muscle disease if the diagnosis is unclear. In pure CMT2N, the main problem is in the nerve, so muscle biopsy findings are usually secondary and may just show signs of denervation and muscle fiber atrophy. MDPI+1
Electrodiagnostic tests
Nerve conduction study (NCS). In this test, small electrical pulses are given to a nerve, and sensors record how fast and how strongly the signal travels. In CMT2N, conduction velocities are often near normal or only slightly reduced, but the response sizes (amplitudes) are low because many axons are lost. This pattern helps distinguish axonal CMT2 from demyelinating CMT1. PMC+2MDPI+2
Electromyography (EMG). A fine needle electrode is inserted into muscles to record their electrical activity. In CMT2N, EMG typically shows chronic denervation and reinnervation changes, which means some muscle fibers have lost their nerve supply while others are being re-supplied by surviving nerves. This confirms that there is a long-standing axonal neuropathy. PMC+1
Imaging tests
MRI of lower limb muscles. Magnetic resonance imaging can show patterns of muscle wasting and fatty replacement in the calves and thighs. Different CMT types can have slightly different MRI patterns, and in some research settings this helps classify the disease and measure progression. www.elsevier.com+1
Ultrasound of peripheral nerves. High-resolution ultrasound can show the size and structure of peripheral nerves in the legs and arms. In some axonal CMT forms, nerves may be slightly enlarged or show subtle structural changes, which can support the diagnosis alongside clinical and genetic tests. MDPI+1
Foot and ankle X-ray. Simple X-rays of the feet and ankles are often used to look at bone alignment, joint damage, and deformities such as high arches or hammertoes. This information helps orthopedic doctors and physiotherapists plan braces, insoles, or surgeries to improve walking and reduce pain. Cleveland Clinic+1
Non-pharmacological treatments (therapies and other approaches)
These treatments do not use drugs. They aim to improve strength, balance, walking, and daily activities, and to prevent falls and deformities.
Individualized physical therapy program
A trained physiotherapist builds a personal exercise plan for stretching, strengthening, balance, and walking practice. The main purpose is to slow muscle wasting, keep joints moving, and reduce stiffness. The therapist teaches safe low-impact exercise like cycling or swimming to avoid over-fatigue. The mechanism is simple: repeated, gentle use of muscles helps them stay as strong as possible and improves brain-to-muscle coordination, even when some axons are damaged. Mayo Clinic+1Balance and gait training
Special exercises help the brain and body work together to keep balance while standing and walking. The purpose is to reduce falls and make walking more efficient, even with weak ankles or foot drop. Therapists may use walking on different surfaces, stepping over obstacles, or treadmill training. The mechanism is “neuroplasticity”: the nervous system learns new patterns to compensate for damaged axons, improving postural control and step symmetry. MDPI+1Stretching and range-of-motion exercises
Daily stretching of calves, hamstrings, toes, and fingers helps prevent joints from becoming locked in a bad position, such as toe-walking or clawed toes. The purpose is to avoid contractures that later may require surgery. Stretching works by lengthening muscles and tendons and reducing uneven pull on bones, which can otherwise worsen deformities in CMT. Mayo Clinic+1Strength training with low resistance
Gentle, low-weight strengthening exercises for core, hip, and shoulder muscles help the body support weak distal muscles. The purpose is to improve overall power for walking, standing from a chair, and lifting. The mechanism is increased muscle fiber size and better motor unit recruitment without overworking already weak nerves; this is why supervised, moderate exercise is recommended instead of heavy gym training. MDPI+1Ankle-foot orthoses (AFOs)
AFOs are light braces worn inside or around the shoes to hold the ankle at a safe angle and prevent foot drop. The purpose is to improve walking, reduce tripping, and decrease fatigue. They work as an external support system: the brace replaces some of the lost muscle function, keeps the foot from slapping the ground, and gives a more stable base during each step. Charcot-Marie-Tooth Association+1Custom shoes and insoles
People with CMT2N often have high arches or hammertoes. Custom shoes and soft insoles spread pressure more evenly under the foot and protect areas with low sensation. The purpose is to prevent ulcers, corns, and pain, and to improve gait. Mechanistically, proper footwear changes how forces move through the foot joints with each step, reducing stress on weak muscles and unstable ankles. Mayo Clinic+1Occupational therapy and adaptive devices
Occupational therapists focus on hand weakness and daily tasks such as dressing, writing, or using a phone. They may suggest button hooks, thicker pen grips, or special keyboards. The purpose is to keep independence in school, work, and self-care. The mechanism is not nerve repair but smart adaptation: tools and techniques reduce the fine-motor effort needed from weak hand muscles. nhs.uk+1Walking aids (cane, crutches, walker, trekking poles)
When leg weakness or balance problems increase, a cane or walker can reduce the risk of falls. The purpose is stability and safety, not giving up walking. These aids work by adding extra “points of contact” with the ground, spreading weight through the arms and giving the brain more feedback about body position. Mayo Clinic+1Podiatry and regular foot care
A podiatrist checks the skin, nails, and pressure areas of the feet, trims nails safely, and treats calluses and minor sores early. The goal is to prevent serious infections and ulcers in numb feet. The mechanism is early detection: when feeling is reduced, visual inspection and professional care replace the lost pain warning system. Mayo Clinic+1Energy conservation and fatigue management
Because weak muscles get tired quickly, learning how to plan the day, rest between tasks, and use chairs or elevators wisely is very helpful. The purpose is to save energy for what matters most, like school, work, or social activities. The mechanism is simple pacing: lowering total strain on nerves and muscles reduces pain flares and long-lasting fatigue. Muscular Dystrophy Association+1Hydrotherapy (water-based exercise)
Swimming or exercising in warm water lets people move with less weight on their joints and feet. The purpose is to keep muscles active while protecting weak ankles and knees. Water supports the body, so the mechanism is unloading: buoyancy decreases impact forces, while water resistance still gently strengthens muscles and improves balance. MDPI+1Night splints and positioning supports
Soft splints worn at night can keep ankles at a neutral angle and prevent worsening of equinus (toe-down) deformity. The goal is to protect alignment while the person sleeps. These devices work by holding joints in a gentle stretch for several hours, helping tendons adapt to a slightly longer, healthier position. Physiopedia+1Hand therapy and fine-motor retraining
Special hand exercises and practice with small tasks (buttons, zippers, writing) train surviving motor units to work more efficiently. The purpose is to keep hand function for as long as possible. The mechanism involves motor learning and strengthening of remaining motor neuron connections, improving coordination even when some axons are lost. Physiopedia+1Assistive technology for communication and school work
Using speech-to-text software, large-key keyboards, or touchscreen devices can greatly help students with weak hands. The purpose is to reduce hand strain and maintain academic performance. The mechanism is compensatory: technology takes over some of the physical work, so the person can focus on thinking and learning instead of fighting with fine-motor tasks. Muscular Dystrophy Association+1Pain coping skills and cognitive-behavioral therapy (CBT)
Chronic neuropathic pain can be stressful and depressing. CBT teaches skills to manage pain, reduce anxiety, and improve sleep. The purpose is not to “say pain is in your head” but to give mental tools that change how the brain processes pain signals. The mechanism is modulation of pain pathways through attention, emotion control, and relaxation techniques. PMC+1Support groups and peer networks
Talking with others who have CMT helps people feel less alone and learn practical tips. The goal is emotional support and shared problem-solving. Support groups work through social connection: hearing how others cope changes beliefs about what is possible and reduces stress, which may indirectly lower pain and fatigue. Mayo Clinic+1Vocational counseling and school accommodations
Planning for the future is important in a lifelong condition. Vocational counselors and school staff can adjust tasks, schedules, or tools to fit physical limits. The purpose is to keep education and work realistic but hopeful. This works by matching a person’s abilities with suitable tasks, reducing frustration and physical over-load. Muscular Dystrophy Association+1Home safety modification and fall-proofing
Simple changes like removing loose rugs, adding grab bars in the bathroom, and improving lighting can prevent dangerous falls. The purpose is to protect bones and joints from fractures. The mechanism is risk reduction: fewer trip hazards plus better light and handholds mean better chances to recover balance when feet do not feel the ground well. Mayo Clinic+1Healthy sleep routine
Poor sleep can make pain and weakness feel worse. Keeping regular bed and wake times, limiting screens before bed, and using relaxation can improve rest. The purpose is to support nerve and muscle recovery overnight. The mechanism is regulation of the body clock and pain-processing centers in the brain, which become more sensitive when sleep is short or irregular. NCBI+1Psychological support and counseling
Living with a chronic genetic disease can cause sadness, anxiety, or low self-esteem. Talking with a psychologist or counselor can help. The purpose is to build coping skills, protect mental health, and support family communication. The mechanism is emotional regulation and problem-solving, which can make physical symptoms easier to manage. NINDS+1
Drug treatments
There are no medicines that cure CMT2N or repair the AARS gene yet. Medicines are used to treat neuropathic pain, muscle cramps, mood, and sleep. Always remember: doses here are general adult ranges from references; real doses must be set by a doctor, and may be different in children and teens.
Pregabalin (Lyrica)
Pregabalin is a “gabapentinoid” anticonvulsant approved by the FDA for several neuropathic pain conditions and seizures. It reduces abnormal nerve firing by binding to calcium channels in nerve cells. Typical adult doses for neuropathic pain are around 150–300 mg per day divided into two or three doses, adjusted by the doctor. Its purpose is to cut burning or shooting nerve pain and improve sleep. Common side effects include dizziness, sleepiness, weight gain, and swelling. NCBI+1Gabapentin (Neurontin, others)
Gabapentin is also a gabapentinoid used widely for neuropathic pain. It works by changing calcium channel activity and reducing release of excitatory neurotransmitters. Adults with neuropathic pain may use about 900–3600 mg per day in divided doses as guided by a doctor. The purpose is to lower nerve pain and improve function. Side effects often include drowsiness, dizziness, and swelling. Abuse risk exists, so it must be used under close medical supervision. FDA Access Data+1Duloxetine (Cymbalta)
Duloxetine is a serotonin–norepinephrine reuptake inhibitor (SNRI) antidepressant. It is FDA-approved for diabetic peripheral neuropathic pain and fibromyalgia. It increases serotonin and norepinephrine in pain pathways in the brain and spinal cord. Typical adult doses for neuropathic pain are 60–120 mg once daily. The purpose is to reduce chronic burning or tingling pain and improve mood. Side effects can include nausea, dry mouth, sweating, and increased blood pressure. FDA Access Data+1Amitriptyline (low-dose tricyclic antidepressant)
Amitriptyline is an older antidepressant used at low dose for nerve pain and poor sleep. It blocks reuptake of serotonin and norepinephrine and also blocks some pain-related receptors. Typical bed-time doses for neuropathic pain are much lower than depression doses (for example 10–75 mg at night in adults), adjusted carefully. The goal is to reduce pain and help sleep. Side effects include dry mouth, constipation, weight gain, and heart rhythm changes, so ECG monitoring may be needed. Cochrane+1Nortriptyline
Nortriptyline is a related tricyclic antidepressant that may be better tolerated in some patients. It also increases serotonin and norepinephrine in pain pathways. Adult starting doses are often around 10–25 mg at bedtime, slowly increased. The purpose is similar to amitriptyline: reducing chronic neuropathic pain and improving sleep quality. Side effects can include dry mouth, dizziness, and heart rhythm changes; it must be avoided in some heart conditions. Cochrane+1Venlafaxine (SNRI)
Venlafaxine is another SNRI that may help neuropathic pain in some people when first-line drugs fail. It blocks reuptake of serotonin and norepinephrine, modulating pain pathways. Adult doses for pain often overlap with those for depression (for example 75–225 mg/day under supervision). The purpose is to reduce pain intensity and improve mood. Side effects include nausea, sweating, insomnia, and possible increases in blood pressure or heart rate. The Lancet+1Carbamazepine
Carbamazepine is an anticonvulsant that stabilizes over-active nerve membranes by blocking sodium channels. It is a classic treatment for trigeminal neuralgia and sometimes used for other neuropathic pains. Typical adult doses range widely (e.g., 400–1200 mg/day in divided doses, guided by blood levels). Its purpose is to reduce sharp, electric-shock-like pains. Side effects may include dizziness, low sodium, liver issues, and rare serious skin reactions. NCBI+1Topical lidocaine patches or gel
Lidocaine is a local anesthetic that blocks sodium channels in nerve endings in the skin. Patches or gels are placed on painful areas for several hours per day. The purpose is to calm shooting or allodynia (pain from light touch) without strong whole-body side effects. Most side effects are local skin irritation; systemic effects are rare when used correctly. Mayo Clinic+1Topical capsaicin cream or high-dose patches
Capsaicin comes from chili peppers and depletes substance P and other pain mediators from small nerve fibers in the skin. Applied regularly, it can slowly reduce burning pain. The purpose is mild pain reduction in localized areas. Early use causes burning or stinging, which usually lessens over time. High-dose patches must be applied in a clinic with supervision. eMedicine+1NSAIDs (e.g., ibuprofen, naproxen)
Non-steroidal anti-inflammatory drugs help mainly with musculoskeletal pain from joint strain or surgery, not with pure neuropathic pain. They work by blocking cyclo-oxygenase enzymes that produce prostaglandins, which cause inflammation and pain. Doses and timing depend on the drug and age. Side effects can include stomach irritation, kidney problems, and increased bleeding risk, especially with long-term use. Wikipedia+1Tramadol
Tramadol is a weak opioid plus SNRI-like drug used for moderate pain when other treatments fail. It acts on mu-opioid receptors and reduces reuptake of serotonin and norepinephrine. Adult doses must be carefully limited (for example up to 300–400 mg/day in divided doses) due to risks of dependence, drowsiness, and seizures, especially with other medicines. It is not a first-line drug in CMT and should be used only short-term under specialist care. eMedicine+1Baclofen
Baclofen is a muscle relaxant that activates GABA-B receptors in the spinal cord, reducing spasticity and cramps. In some CMT patients with painful muscle spasms, it may help. Adult oral doses are usually slowly increased from low levels to avoid side effects like drowsiness and weakness. The purpose is to ease tight, cramping muscles. Sudden stop can cause withdrawal, so tapering is important. Physiopedia+1Tizanidine
Tizanidine is another muscle relaxant that acts on alpha-2 adrenergic receptors to reduce muscle tone. It may be used when cramps or spasticity cause pain or poor sleep. The mechanism is decreased excitatory input to motor neurons. Side effects include low blood pressure, sleepiness, and dry mouth, so monitoring is needed. Physiopedia+1Clonazepam (for severe nocturnal cramps or anxiety)
Clonazepam is a benzodiazepine that enhances GABA’s calming effect in the brain. In some cases, it is used short-term for severe night cramps or anxiety linked with chronic disease. The purpose is muscle relaxation and reduced anxiety, but dependence and sedation risks are high. It must be used very carefully and usually for brief periods only. eMedicine+1Selective serotonin reuptake inhibitors (SSRIs) for mood
Drugs like sertraline or fluoxetine do not treat neuropathic pain directly but can help depression or anxiety common in chronic illness. They work by increasing serotonin levels in the brain. Improved mood can make coping with pain and disability easier. Side effects include stomach upset, sleep changes, and in some people, increased agitation. NINDS+1Melatonin or short-term sleep aids
Melatonin helps synchronize the sleep–wake cycle, especially when chronic pain breaks sleep. It acts on melatonin receptors in the brain’s clock center. Improving sleep can indirectly reduce pain sensitivity and fatigue. Other sleep aids may be used in adults, but they carry risks of dependence and morning grogginess. Non-drug sleep strategies are always preferred first. NCBI+1Vitamin D supplementation (when deficient)
Vitamin D is not a painkiller, but low levels are common in people with limited activity. Correcting deficiency supports bone health and may slightly help muscle function and mood. The mechanism involves calcium balance and muscle cell function. Doses depend on blood test results and must be guided by a clinician to avoid toxicity. NINDS+1Magnesium (for cramps if low)
Low magnesium can worsen muscle cramps. In clearly deficient people, supplementation can help reduce spasms by stabilizing muscle cell membranes and supporting normal nerve–muscle transmission. Excess magnesium can cause diarrhea and, in high doses, heart or breathing problems, so laboratory monitoring is needed. Physiopedia+1Short-term opioids after surgery only
Strong opioids (like morphine) may be used for a few days after corrective surgery. They bind to opioid receptors to block pain signals. They are not a long-term treatment for CMT pain because of dependence and side effects like constipation and drowsiness. The goal is only short-term relief during acute post-operative pain. eMedicine+1Combination therapy (e.g., pregabalin plus amitriptyline)
Sometimes doctors use lower doses of two different drugs instead of a high dose of one, aiming for better pain control with fewer side effects. For example, a gabapentinoid plus a tricyclic antidepressant may be combined in diabetic neuropathic pain. The mechanism is targeting different steps of pain processing at the same time. This must be supervised by a specialist to avoid dangerous interactions. The Lancet+1
Dietary molecular supplements
Supplements do not cure CMT2N. Evidence is limited, and many claims online are not proven. These examples are general; always check with a doctor first.
Alpha-lipoic acid – An antioxidant used in diabetic neuropathy research; it may reduce oxidative stress around nerves. Proposed doses in adults are often 300–600 mg/day, but long-term safety for CMT is not well studied. PMC+1
Acetyl-L-carnitine – Involved in mitochondrial energy production; may support nerve energy use and has been studied in some neuropathies. Adult doses in studies were around 500–1000 mg two or three times daily. PMC+1
Omega-3 fatty acids (fish oil) – Have anti-inflammatory and membrane-stabilizing effects, which might support nerve cell health. Typical adult doses are around 1–3 g/day of EPA+DHA. NINDS+1
Coenzyme Q10 – Supports mitochondrial electron transport and energy production; sometimes used in mitochondrial and neuromuscular disorders. Doses in studies range from 100–300 mg/day. PMC+1
Vitamin B12 (methylcobalamin) – Essential for myelin and axon health. In deficiency-related neuropathy, injections or high-dose oral tablets can help. In CMT, B12 should at least be kept in the normal range; doses depend on blood levels. NINDS+1
Vitamin B1 (thiamine) and B6 (pyridoxine) – carefully dosed – Normal levels are important for nerve function, but too much B6 can actually cause neuropathy. Balanced B-complex, not mega-doses, may be used if diet is poor. Physiopedia+1
Vitamin D – As noted above, important for bone health and muscle support, especially in people with limited sun exposure or walking. NINDS+1
Magnesium – If blood levels are low, correction may reduce cramps and support normal muscle contraction. NCBI+1
Curcumin (turmeric extract) – Has anti-inflammatory and antioxidant effects in experimental studies. Human data in CMT are lacking, so it should be seen as experimental and used in food amounts, not high doses, unless supervised. PMC+1
Resveratrol or other polyphenols – These plant compounds show neuro-protective effects in lab models, but clinical proof in CMT is still missing. If used, they should complement, not replace, standard care. PMC+1
Immune-booster, regenerative and stem-cell-related drugs
For CMT2N there are no FDA-approved regenerative or stem cell drugs yet. Research is mostly in early stages.
Gene-targeted therapies (research)
Scientists are exploring gene therapy to correct mutations or modulate gene expression in axonal CMT, including MFN2- and AARS-related forms. The purpose is to fix the underlying genetic error rather than only treating symptoms. Mechanisms include viral vectors that deliver healthy gene copies to nerve cells. This is still experimental and only available in clinical trials. PMC+1Neurotrophic factors (e.g., NT-3) in trials
Neurotrophic factors are natural proteins that support nerve growth and survival. In some CMT studies, neurotrophin-3 (NT-3) and similar molecules have been tested. They aim to protect axons and improve muscle strength by enhancing nerve repair pathways. So far, results are mixed and not yet ready for routine clinical use. PMC+1Small-molecule modulators of mitochondrial function
Because many axonal CMTs are linked to mitochondrial problems, drugs that improve mitochondrial dynamics are under study. They aim to restore energy balance and reduce axonal degeneration. At present, these molecules are experimental and used only in research settings. PMC+1Anti-oxidant drug combinations
Some trials combine antioxidant drugs to reduce oxidative stress in nerves. The idea is to protect axonal membranes from long-term damage. Evidence is not strong enough to recommend any specific combination yet for CMT2N. PMC+1Cell-based therapies (experimental stem cell approaches)
Researchers are studying ways to use stem cells to deliver supportive factors or replace damaged cells in peripheral nerves. These approaches are still at the laboratory or early-trial level and are not standard care. People with CMT should avoid commercial “stem cell clinics” that promise cures without solid evidence. PMC+1Vaccination and infection prevention (indirect immune support)
Keeping up-to-date with routine vaccines (such as flu and COVID-19) reduces severe systemic illness that might temporarily worsen weakness and fatigue. This does not regenerate nerves but helps the body focus energy on long-term nerve health instead of repeated infections. NINDS+1
Surgeries
Surgery in CMT2N is usually for foot and skeletal deformities, not for the nerves themselves.
Soft tissue release (tendon lengthening or transfer)
Surgeons may lengthen tight Achilles tendons or transfer tendons from stronger muscles to weaker ones (for example, to help lift the foot). The purpose is to correct imbalance and improve walking. Mechanically, this redistributes muscle forces across the ankle and foot, making gait more stable. Physiopedia+1Osteotomy (bone cutting and realignment)
In people with severe cavovarus foot (high arch and inward-turning heel), parts of bones are cut and repositioned. The goal is to create a flatter, more plantigrade foot. This improves weight-bearing and reduces pain by changing the shape of the foot skeleton. Physiopedia+1Arthrodesis (joint fusion)
If joints are very unstable or deformed, the surgeon may fuse them so they no longer move. Fusion can provide a solid base for walking but sacrifices flexibility. The purpose is pain relief and stability when other options fail. Physiopedia+1Hand tendon transfer surgery
In advanced hand weakness, tendon transfers may improve grip or pinch. The surgeon reroutes tendons from still-working muscles to those that no longer function. The mechanism is similar to foot tendon transfers: moving the “pulling force” to where it is most helpful. eMedicine+1Spine surgery for scoliosis (if present)
Some people with neuromuscular conditions develop spinal curvature. If scoliosis becomes severe and affects posture or breathing, spinal fusion may be needed. The purpose is to prevent progression and protect lung function. eMedicine+1
Prevention and self-care
Because CMT2N is genetic, we cannot currently prevent the disease itself, but we can reduce complications.
Genetic counseling for families – Helps relatives understand inheritance risks and testing options. Mayo Clinic+1
Avoid known neurotoxic drugs (e.g., some chemotherapy agents) when alternatives exist, under oncologist guidance. NINDS+1
Keep a regular exercise routine with low-impact activities to maintain strength without over-fatigue. MDPI+1
Protect feet daily – inspect skin, wear well-fitting shoes, and treat small wounds early. Mayo Clinic+1
Use braces or aids early rather than late to prevent falls and joint damage. Charcot-Marie-Tooth Association+1
Keep a healthy body weight to reduce strain on weak muscles and joints. MSD Manuals+1
Avoid smoking and heavy alcohol use, which can harm nerves further. NINDS+1
Maintain good blood sugar control if you have diabetes, to avoid extra neuropathy damage. FDA Access Data+1
Prevent falls at home by tidy floors, good lighting, and bathroom grab bars. Mayo Clinic+1
Stay connected with specialists (neurologist, physiatrist, therapist) for regular review and updates on research. Muscular Dystrophy Association+1
When to see a doctor
You should see a doctor regularly if you have CMT2N, but urgent review is needed if:
You notice sudden or fast-worsening weakness, especially in breathing, swallowing, or hands. NINDS+1
You develop new severe pain, burning, or electric-shock feelings that do not improve with usual medicines. NCBI+1
You have repeated falls, new foot ulcers, or infections that do not heal quickly. Mayo Clinic+1
You see change in the shape of your foot, ankle, or spine, suggesting worsening deformity. Physiopedia+1
You are thinking about pregnancy or family planning and want genetic counseling. ZFIN+1
For any teenager, it is especially important that medicines and supplements are checked by a pediatric neurologist or another specialist, because dose and side-effect risks are different from adults.
What to eat and what to avoid
Eat plenty of vegetables and fruits – They provide vitamins, minerals, and antioxidants that support general nerve and muscle health. NINDS+1
Choose lean proteins (fish, eggs, beans, poultry) to help maintain muscle mass in weak limbs. MSD Manuals+1
Include healthy fats like olive oil, nuts, and omega-3-rich fish; these support cell membranes and may reduce inflammation. NINDS+1
Stay well-hydrated with water; dehydration can worsen fatigue and cramps. Physiopedia+1
Avoid very high-sugar foods and drinks, which can promote weight gain and, in diabetes, worsen neuropathy. FDA Access Data+1
Limit highly processed fast food, which often contains unhealthy fats and excess salt. MSD Manuals+1
Avoid heavy alcohol use, which can directly damage peripheral nerves and worsen balance. NINDS+1
Be cautious with “mega-dose” supplements advertised as nerve cures; evidence is weak and side effects may be serious. PMC+1
Aim for a stable, healthy weight through balanced diet and activity, so joints and muscles are not overloaded. MSD Manuals+1
If you are underweight due to fatigue or poor appetite, talk with a dietitian for a high-calorie, nutrient-dense plan rather than relying only on pills. NINDS+1
Frequently asked questions
Is CMT2N life-threatening?
CMT2N is usually a mild to moderate, slowly progressive neuropathy. Most people have a normal life span, but they may have increasing disability over time. Serious life-threatening complications are uncommon, but falls, fractures, and severe deformities can greatly reduce quality of life if not managed early. monarchinitiative.org+1Can CMT2N be cured?
At present there is no cure that reverses the genetic change in the AARS gene or fully restores damaged axons. Treatment focuses on rehabilitation, bracing, pain control, and sometimes surgery. Researchers are working on gene therapies and other disease-modifying approaches, but these are not yet available for routine care. PMC+1Will exercise make my nerves worse?
Appropriate, supervised, low-impact exercise is helpful, not harmful, for most people with CMT. Over-exertion that causes strong pain or long-lasting fatigue is not good, so a physiotherapist should guide intensity and type of exercise. MDPI+1Why are braces and orthotics so important?
Braces and orthotics act like an external muscle and skeleton. They support weak ankles and feet, prevent falls, and spread pressure evenly. Using them early can delay or reduce the need for surgery and protect joints. Charcot-Marie-Tooth Association+1Are pain medicines safe to take for a long time?
Some drugs, like gabapentinoids or antidepressants used for pain, can be taken long term under medical supervision, but they all have side effects and may need regular review. Strong opioids and benzodiazepines should not be used long term for chronic CMT pain because of high risks of dependence and other harms. NCBI+1Do I need genetic testing?
Genetic testing can confirm the exact CMT subtype (like CMT2N) and help with family planning and research eligibility. It may not change current treatment options but can provide clarity and prevent unnecessary tests. A genetic counselor can explain pros and cons. Mayo Clinic+1Can diet alone fix my nerve damage?
No diet can repair the AARS mutation or fully regrow axons. However, a healthy, balanced diet supports muscles, bones, and overall health, and helps you respond better to rehabilitation and surgery if needed. NINDS+1Is CMT2N the same as diabetic neuropathy?
No. CMT2N is an inherited axonal neuropathy from a gene mutation, while diabetic neuropathy is caused by long-term high blood sugar. But both cause numbness, burning pain, and weakness in the feet and hands, and some treatments for neuropathic pain are similar. ZFIN+1Can children and teenagers take the same medicines as adults?
Some neuropathic pain medicines are approved or studied in children, but dosing and safety are different, and some are not recommended in younger people. A pediatric neurologist must decide what is safe for a teenager; never copy adult doses. FDA Access Data+1Will I end up in a wheelchair?
Many people with CMT never need a wheelchair full-time, especially with early therapy, bracing, and surgery when needed. Others may use a wheelchair for long distances while still walking short distances with aids. Every person’s path is different. nhs.uk+1Can pregnancy make CMT2N worse?
In some women with CMT, symptoms like weakness or balance problems may temporarily worsen during pregnancy because of weight gain and hormonal changes, but data are limited. Pre-pregnancy counseling with a neurologist and obstetrician is recommended. NINDS+1Should I avoid certain sports?
High-impact sports with a high fall risk (like contact sports or trampolining) are usually discouraged, especially with weak ankles. Low-impact activities such as swimming, cycling, and gentle gym workouts are safer and still very helpful. MDPI+1Is it worth joining clinical trials?
Clinical trials are how we discover better treatments. For some CMT subtypes, trials may test new drugs, gene therapies, or advanced rehab methods. Participation can offer access to new options but also has risks. A specialist can help you evaluate specific trials. PMC+1Can CMT2N affect my breathing or heart?
Most people with axonal CMT2N do not have major breathing or heart problems, but severe foot or spine deformities may indirectly affect posture and lung function. Any new shortness of breath, chest pain, or palpitations should be checked quickly. NINDS+1What is the most important thing I can do right now?
The most important steps are: work with a neurologist and rehabilitation team, protect your feet, stay active with safe exercise, use braces or aids when recommended, and look after your mental health. These actions cannot cure CMT2N but can strongly improve quality of life over the long term. Muscular Dystrophy Association+1
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.
